To investigate whether IGF-signaling pathways are activated in invasive breast cancer progression and whether their activation correlates with macrophage infiltration, we first evaluated the activation status of insulin and IGF-1 receptors in biopsies from breast cancer patients, and the levels of infiltrated TAMs. The gene discussed is INS; the disease is breast carcinoma.